Image For Activity Cover
Quinidine in the Management of Recurrent Ventricular Arrhythmias: A Reappraisal - JCEP October 2021
Quinidine in the Management of Recurrent Ventricular Arrhythmias: A Reappraisal - JCEP October 2021
Therapeutic options are often limited in patients with structural heart disease and recurrent ventricular arrhythmias (VA). Quinidine has an established role in rare arrhythmic syndromes, but its potential use in other difficult VA has not been assessed in the present era.  In patients with recurrent VA and structural heart disease who have limited treatment options, quinidine can be useful, particularly as a short-term therapy. 


Editor-in-Chief
Kalyanam Shivkumar, MD, PhD, FACC 

CME Editor
Kenneth A. Ellenbogen, MD

Author
Kenneth A. Ellenbogen, MD

Important Dates
Date of Release: October 18, 2021   
Term of Approval/Date of CME/MOC/ECME Expiration: October 17, 2022
Summary
Availability: On-Demand
Expires on Oct 17, 2022
Cost: FREE
Credit Offered:
1 CME Credit
1 ABIM-MOC Point
1 ECME Credit
Android App Download IOS App Download Powered By